Literature DB >> 10785949

[LEEP versus cold knife conization for treatment of cervical intraepithelial neoplasias].

P Hillemanns1, R Kimmig, C Dannecker, T Noorzai, J Diebold, C J Thaler, H Hepp.   

Abstract

OBJECTIVE: This study was performed to evaluate the effectiveness and side effects of loop electrosurgical excision procedure (LEEP) in comparison to cold knife conization for the treatment of cervical intraepithelial neoplasia (CIN).
MATERIAL AND METHODS: Between January 1996 and July 1998, 177 patients underwent conization. In a matched-pair setting, 50 cases with LEEP were compared with 100 classical conization cases. LEEP was performed with ectocervical and endocervical excision.
RESULTS: Perioperative complications were less in the LEEP group (6% vs. 11%). The mean volume of LEEP specimens (1.6 cm3) was significantly smaller than the volume of cone specimens (2.6 cm3). Thermal artifacts were negligible. There were no significant differences in the proportion of margin involvement (20% vs. 19%) and residual/recurrent CIN. The endocervical excision contained dysplastic tissue in 38% of the cases; more important, a positive endocervical excision was found in 14/21 CIN 3 cases (67%). The success rate, was similar in both groups (96% vs. 97%). Hospitalization time was less for the LEEP group.
CONCLUSIONS: LEEP conization is a safe and cost effective procedure with a lower complication rate providing a significantly smaller specimen compared to cold knife conization. Therefore, LEEP conization may substitute cold knife conization. However, we do recommend to perform LEEP conization with an endocervical excision to reduce residual CIN.

Entities:  

Mesh:

Year:  2000        PMID: 10785949

Source DB:  PubMed          Journal:  Zentralbl Gynakol        ISSN: 0044-4197


  1 in total

1.  Value of second pass in loop electrosurgical excisional procedure.

Authors:  Kidong Kim; Soon-Beom Kang; Hyun Hoon Chung; Tack-Sang Lee; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.